Anthony Petrone
Stock Analyst at Mizuho
(3.72)
# 776
Out of 5,005 analysts
193
Total ratings
49.28%
Success rate
7.89%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Outperform | $65 → $70 | $62.84 | +11.39% | 3 | Sep 25, 2025 | |
| ALC Alcon | Maintains: Outperform | $120 → $110 | $77.38 | +42.16% | 10 | Aug 21, 2025 | |
| HAE Haemonetics | Maintains: Outperform | $90 → $70 | $50.49 | +38.64% | 15 | Aug 8, 2025 | |
| LNTH Lantheus Holdings | Maintains: Outperform | $120 → $70 | $53.83 | +30.04% | 6 | Aug 7, 2025 | |
| RMD ResMed | Maintains: Outperform | $270 → $290 | $278.59 | +4.10% | 17 | Aug 1, 2025 | |
| TFX Teleflex | Maintains: Neutral | $130 → $135 | $130.90 | +3.13% | 9 | Aug 1, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $87 → $95 | $77.07 | +23.26% | 9 | Jul 25, 2025 | |
| ABT Abbott Laboratories | Maintains: Neutral | $140 → $135 | $134.59 | +0.30% | 6 | Jul 18, 2025 | |
| COO The Cooper Companies | Maintains: Outperform | $105 → $90 | $70.46 | +27.73% | 15 | Jul 16, 2025 | |
| STAA STAAR Surgical Company | Maintains: Neutral | $17 → $18 | $27.14 | -33.68% | 8 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $98 → $100 | $97.70 | +2.35% | 7 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $70 | $68.22 | +2.61% | 9 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $58 → $70 | $41.43 | +68.96% | 7 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $12 | $14.32 | -16.20% | 3 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $100 | $67.05 | +49.14% | 2 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $200 → $175 | $87.41 | +100.21% | 10 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2 | $0.46 | +331.97% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $20 | $14.71 | +35.96% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $60 | $56.72 | +5.78% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $58 | $65.17 | -11.00% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $60 | $53.37 | +12.42% | 8 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $110 | $97.32 | +13.03% | 8 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $14 | $14.66 | -4.50% | 6 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $105 | $76.56 | +37.15% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 | $76.58 | +226.46% | 6 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $7.21 | +94.17% | 4 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $390 | $452.35 | -13.78% | 6 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $87.85 | -23.73% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $100.78 | +73.65% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $11.94 | +109.38% | 3 | May 13, 2020 |
Guardant Health
Sep 25, 2025
Maintains: Outperform
Price Target: $65 → $70
Current: $62.84
Upside: +11.39%
Alcon
Aug 21, 2025
Maintains: Outperform
Price Target: $120 → $110
Current: $77.38
Upside: +42.16%
Haemonetics
Aug 8, 2025
Maintains: Outperform
Price Target: $90 → $70
Current: $50.49
Upside: +38.64%
Lantheus Holdings
Aug 7, 2025
Maintains: Outperform
Price Target: $120 → $70
Current: $53.83
Upside: +30.04%
ResMed
Aug 1, 2025
Maintains: Outperform
Price Target: $270 → $290
Current: $278.59
Upside: +4.10%
Teleflex
Aug 1, 2025
Maintains: Neutral
Price Target: $130 → $135
Current: $130.90
Upside: +3.13%
Edwards Lifesciences
Jul 25, 2025
Maintains: Outperform
Price Target: $87 → $95
Current: $77.07
Upside: +23.26%
Abbott Laboratories
Jul 18, 2025
Maintains: Neutral
Price Target: $140 → $135
Current: $134.59
Upside: +0.30%
The Cooper Companies
Jul 16, 2025
Maintains: Outperform
Price Target: $105 → $90
Current: $70.46
Upside: +27.73%
STAAR Surgical Company
Jul 16, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $27.14
Upside: -33.68%
Jul 16, 2025
Maintains: Outperform
Price Target: $98 → $100
Current: $97.70
Upside: +2.35%
Jul 16, 2025
Maintains: Outperform
Price Target: $65 → $70
Current: $68.22
Upside: +2.61%
Jul 16, 2025
Maintains: Outperform
Price Target: $58 → $70
Current: $41.43
Upside: +68.96%
Jul 16, 2025
Maintains: Neutral
Price Target: $13 → $12
Current: $14.32
Upside: -16.20%
Jul 16, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $67.05
Upside: +49.14%
Apr 16, 2025
Maintains: Outperform
Price Target: $200 → $175
Current: $87.41
Upside: +100.21%
Apr 10, 2025
Initiates: Outperform
Price Target: $2
Current: $0.46
Upside: +331.97%
Apr 10, 2025
Initiates: Neutral
Price Target: $20
Current: $14.71
Upside: +35.96%
Apr 10, 2025
Initiates: Outperform
Price Target: $60
Current: $56.72
Upside: +5.78%
Mar 6, 2025
Maintains: Buy
Price Target: $54 → $58
Current: $65.17
Upside: -11.00%
Feb 26, 2025
Maintains: Outperform
Price Target: $70 → $60
Current: $53.37
Upside: +12.42%
Oct 24, 2024
Maintains: Outperform
Price Target: $100 → $110
Current: $97.32
Upside: +13.03%
Jun 20, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $14.66
Upside: -4.50%
May 1, 2024
Maintains: Buy
Price Target: $110 → $105
Current: $76.56
Upside: +37.15%
Mar 27, 2024
Maintains: Buy
Price Target: $250
Current: $76.58
Upside: +226.46%
Mar 1, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $7.21
Upside: +94.17%
Jan 25, 2024
Maintains: Neutral
Price Target: $350 → $390
Current: $452.35
Upside: -13.78%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $87.85
Upside: -23.73%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $100.78
Upside: +73.65%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $11.94
Upside: +109.38%